PER1 and prostate carcinoma: Previous studies have also reported that aberrant expression and dampened rhythm of PER1 intimately linked to the inception and progression of malignant tumours, such as colon cancer, prostate cancer, breast cancer and non-small cell lung cancer (NSCLC) [42, 44–46].